Milestone Pharmaceuticals Income Statement (2018-2026) | MIST

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
15.00M1.50M
Operating items
Research & Development (Quarter)
9.43M9.73M10.92M10.66M9.83M
Selling, General & Administrative (Quarter)
3.02M2.96M3.79M3.92M4.03M
Operating Expenses (Quarter)
12.45M12.69M14.70M14.57M13.86M
Operating Income (Quarter)
0.71M-14.27M-16.92M-16.81M-15.03M
EBIT (Quarter)
0.71M-14.27M-16.92M-16.81M-15.03M
Non-operating items
Interest & Investment Income (Quarter)
0.06M0.05M0.03M
Non Operating Income (Quarter)
0.06M0.05M0.16M0.47M
Net income details
EBT (Quarter)
0.77M-14.22M-16.88M-16.81M-15.03M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
0.77M-14.22M-16.88M-16.65M-14.56M
Income from Continuing Operations (Quarter)
0.77M-14.22M-16.88M-16.81M-15.03M
Consolidated Net Income (Quarter)
0.77M-14.22M-16.88M-16.81M-15.03M
Income towards Parent Company (Quarter)
0.77M-14.22M-16.88M-16.81M-15.03M
Net Income towards Common Stockholders (Quarter)
0.77M-14.22M-16.88M-16.81M-15.03M
Additional items
EPS (Basic) (Quarter)
0.02-0.34-0.40-0.40-0.35
Shares Outstanding (Quarter)
41.67M42.19M41.83M42.24M42.28M42.49M42.45M42.85M42.94M42.97M42.96M50.16M66.17M66.19M62.21M66.29M66.38M96.49M83.88M130.29M
EBITDA (Quarter)
0.71M-14.27M-16.92M-16.81M-15.03M
Interest Expenses (Quarter)
53.52M65.91M2.68M2.12M2.06M0.86M1.92M1.85M1.78M0.92M1.62M1.54M1.45M0.98M1.27M
Tax Rate (Quarter)